-Hideaki Hanaki Researcher Activity Profile

Research Author Detailed Information 

Hideaki Hanaki Publication Rate By Year

Hideaki Hanaki has published 8 paper(s) in 2007, for a total of 8 research publications in total.

Hideaki H Hanaki Author Information

LAST NAME: hanaki

FIRST NAME: hideaki

INITIALS: H

AFFILIATION:

Papers

Hideaki Hanaki's Publication Record

1. Trends of beta-lactam antibiotic susceptibility in blood-borne methicillin-resistant Staphylococcus aureus (MRSA) and their linkage to the staphylococcal cassette chromosome mec (SCCmec) type. Year Published: 2007
Laboratory of Infectious Diseases, Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Tokyo 108-8642, Japan. p98224@st.pharm.kitasato-u.ac.jp
2. Design and synthesis via click chemistry of 8,9-anhydroerythromycin A 6,9-hemiketal analogues with anti-MRSA and -VRE activity. Year Published: 2007
Kitasato Institute for Life Sciences and Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, Japan.
3. Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin. Year Published: 2007
Kitasato Research Center for Anti-infection Drugs, 5-9-1 Shirokane, Minato-Ku, Tokyo, 108-0072, Japan, chieyanagisawa131@yahoo.co.jp.
4. Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs). Year Published: 2007
Research Center for Anti-Infective Drugs, Kitasato Institute, Minato-ku, Tokyo, Japan.
5. Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin. Year Published: 2007
Kitasato Research Center for Anti-infection Drugs, 5-9-1 Shirokane, Minato-Ku, Tokyo 108-0072, Japan. chieyanagisawa131@yahoo.co.jp
6. Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs). Year Published: 2007
Research Center for Anti-Infective Drugs, Kitasato Institute, Minato-ku, Tokyo, Japan.
7. Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin. Year Published: 2007
Kitasato Research Center for Anti-infection Drugs, 5-9-1 Shirokane, Minato-Ku, Tokyo 108-0072, Japan. chieyanagisawa131@yahoo.co.jp
8. Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs). Year Published: 2007
Research Center for Anti-Infective Drugs, Kitasato Institute, Minato-ku, Tokyo, Japan.